Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal
Alnylam Pharmaceuticals announced its first discovery-focused AI deal Wednesday, tapping a Silicon Valley biotech startup to see if AI can boost its R&D efforts. Alnylam and Inceptive signed a collaboration combining the Cambridge, MA-based company's ...
June 3, 2026 04:45 PM EDT DealsR&DAI Alnylam signs its first AI discovery deal with RNA specialist Inceptive Andrew Dunn Senior Biopharma Correspondent Alnylam Pharmaceuticals announced its first discovery-focused AI deal Wednesday, tapping a Silicon Valley biotech startup to see if AI can boost its R&D efforts. Alnylam … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that